The landscape of scalp loss therapies is undergoing a dramatic change, with cellular deliveries emerging as a highly potential avenue for regrowing density. Unlike traditional therapies that primarily focus on slowing hair shedding, this novel procedure aims to encourage the redevelopment of damaged follicles, essentially revitalizing the scalp'